Your browser doesn't support javascript.
loading
Impact of disease-modifying therapies on humoral and cellular immune-responses following SARS-CoV-2 vaccination in MS patients.
Trümpelmann, Susan; Schulte-Mecklenbeck, Andreas; Steinberg, Olga V; Wirth, Timo; Fobker, Manfred; Lohmann, Lisa; Lünemann, Jan D; Wiendl, Heinz; Gross, Catharina C; Klotz, Luisa.
Afiliación
  • Trümpelmann S; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Schulte-Mecklenbeck A; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Steinberg OV; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Wirth T; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Fobker M; Central Laboratories, University Hospital Münster, Münster, Germany.
  • Lohmann L; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Lünemann JD; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Wiendl H; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Gross CC; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
  • Klotz L; Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany.
Clin Transl Sci ; 15(7): 1606-1612, 2022 07.
Article en En | MEDLINE | ID: mdl-35213793
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Tratamiento Farmacológico de COVID-19 / Esclerosis Múltiple Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Clin Transl Sci Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Tratamiento Farmacológico de COVID-19 / Esclerosis Múltiple Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Clin Transl Sci Año: 2022 Tipo del documento: Article País de afiliación: Alemania